<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15119">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02121808</url>
  </required_header>
  <id_info>
    <org_study_id>IUCPQ 21054</org_study_id>
    <nct_id>NCT02121808</nct_id>
  </id_info>
  <brief_title>EPO2-PV: Evaluation of Pre-Oxygenation Conditions in Morbidly Obese Volunteer: Effect of Position and Ventilation Mode</brief_title>
  <acronym>EPO2-PV</acronym>
  <official_title>Evaluation of Different Pre-Oxygenation Conditions in Morbid Obesity: Position and Ventilation Mode, in a Respiratory Physiology Laboratory, on Voluntary Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The risk of complications associated with airway management in obese patients is
      significant. The results of pre-oxygenation allow a prolonged non-hypoxic apnea time for the
      clinician. The increase in FRC and non-hypoxic apnea time is correlated. The best condition
      to accomplish the pre-oxygenation in morbidly obese patient is still undetermined in medical
      literature.

      This study is designed to evaluate the effect of different positions combined with different
      ventilation modes during the pre-oxygenation phase of anesthesia's induction. EPO2: PV will
      evaluate the effect of different combinations of positions and ventilation modes on
      pulmonary volumes (mainly functional residual capacity) in a morbidly obese volunteer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Complications related to airway management are the major contributing factor to morbidity in
      anesthesiology. This risk of complications markedly increases when faced with a difficult
      airway in an obese patient. Pre-oxygenation creates a safety margin by increasing the
      patient's oxygen stores, through a higher functional residual capacity (FRC). When
      pre-oxygenated, the clinician may proceed to intubation after a variable period of apnea,
      while maintaining oxygen saturation over 92%. In non-obese individuals, pre-oxygenation
      allows a non-hypoxic apnea time of eight minutes. In the obese population, however, this
      non-hypoxic apnea time decreases to two to three minutes.

      Different methods of pre-oxygenation have been proposed in order to increase apnea time
      before significant oxygen desaturation. Amongst these methods, the following are of
      particular interest: pre-oxygenation to vital capacity, pre-oxygenation with spontaneous
      ventilation and positive pressure, and pre-oxygenation with elevated head positioning
      (&quot;beach-chair&quot;). These methods have been extensively studied in individuals of normal height
      and weight.

      The main objective of pre-oxygenation is to raise oxygen levels available at the alveolar
      level in order to increase the non-hypoxic apnea time, before a significant desaturation
      occurs. This raised alveolar oxygen concentration can be done by maintaining a higher
      inspired oxygen fraction and by promoting a larger FRC which is the oxygen reserve build
      through the pre-oxygenation phase. In morbid obese patients, these parameters are affected
      by a lower expiratory flow, lower expiratory flow and closing of small radius airways. The
      final result probably come from a more cephalad position of the diaphragm induced by a
      larger intra-abdominal volume.

      Actually, different studies demonstrate the advantage of a beach-chair position and
      non-invasive positive pressure ventilation for pre-oxygenation of obese patients. These
      advantages are shown by a shorter time of pre-oxygenation to obtain an end-tidal O2 &gt; 90 %
      and a longer non-hypoxic apnea time (Sat O2 &gt;90%). Up to date, there is no published data on
      the FRC as a result of different combinations of position and ventilation mode. This study
      will evaluate FRC by helium dilution technique.

      We propose a crossover randomised trial on volunteers waiting for a bariatric surgery. We
      want to compare, in pre-oxygenation situation, without induction of general anesthesia, the
      effect of three positions and two ventilation modes on the FRC measure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Functional residual capacity</measure>
    <time_frame>After a 5 minutes pre-oxygenation period</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Change of functional residual capacity (FRC), in obese patient, as a result of different pre-oxygenation positions; 1- supine, 2-beach-chair, 3- reverse Trendelenburg, in two different ventilation modes : 1- spontaneous ventilation at tidal volume, 2- non-invasive positive pressure ventilation with inspiratory assistance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic amplitude.</measure>
    <time_frame>After a 5 minutes pre-oxygenation period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of changes in diaphragmatic amplitude and movement determined by fluoroscopy imaging after a 5 minutes pre-oxygenation period in the 6 combinations previously described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory mechanics</measure>
    <time_frame>At the end of a 5 minutes pre-oxygenation period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in respiratory mechanics (compliance, resistance, tidal volume, positive end-expiratory pressure, maximal inspiratory pressure) evaluated at the end of a 5 minutes pre-oxygenation period in the 6 combinations previously described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's comfort</measure>
    <time_frame>At the end of a 5 minutes pre-oxygenation period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of the patient's comfort at the end of each intervention on an analog visual scale after a 5 minutes pre-oxygenation period in the 6 combinations previously described.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Vital signs</measure>
    <time_frame>At the end of a 5 minutes pre-oxygenation period</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in vital signs before and after the pre-oxygenation phase in the 6 combinations after a 5 minutes pre-oxygenation period in the 6 combinations previously described.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>Supine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NIPPV and Tidal volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beach-chair (Back : 25 deg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NIPPV and Tidal volume</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Proclive (Global 25 deg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NIPPV and Tidal volume</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NIPPV</intervention_name>
    <description>Ventilation: non-invasive positive pressure ventilation (NIPPV)
Positive end-expiratory pressure: 10 cmH20 Pressure support: 5 - 20 cm H2O for tidal volume of 10 mL / kg (ideal body weight)</description>
    <arm_group_label>Supine</arm_group_label>
    <arm_group_label>Beach-chair (Back : 25 deg)</arm_group_label>
    <arm_group_label>Proclive (Global 25 deg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tidal volume</intervention_name>
    <description>Tidal volume spontaneous ventilation, no assistance.</description>
    <arm_group_label>Supine</arm_group_label>
    <arm_group_label>Beach-chair (Back : 25 deg)</arm_group_label>
    <arm_group_label>Proclive (Global 25 deg)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 40 - 80 kg / m2

          -  Waist circumference: Men: More than 130 cm

          -  Waist circumference: Women: More than 115 cm

        Exclusion Criteria:

          -  Facial hair

          -  Cranio-facial abnormality

          -  Claustrophobia

          -  Asthma

          -  COPD (defined by FEV1 &lt; 80 %)

          -  Severe cardiovascular disease (defined by NYHA â‰¥3)

          -  Pregnancy

          -  Tobacco use

          -  NI-CPPV Intolerance documented by a respiratory specialist (pneumologist).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Etienne J Couture, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean S BussiÃ¨res, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean S BussiÃ¨res, MD</last_name>
    <phone>418 656-8711</phone>
    <phone_ext>2944</phone_ext>
    <email>jbuss@criucpq.ulaval.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Etienne J Couture, MD</last_name>
    <phone>418 656-8711</phone>
    <phone_ext>2660</phone_ext>
    <email>etienne.couture.3@ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut universitaire de cardiologie et de pneumologie de QuÃ©bec</name>
      <address>
        <city>Quebec city</city>
        <state>Quebec</state>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean S BussiÃ¨res, MD</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>2944</phone_ext>
      <email>jbuss@criucpq.ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Nathalie GagnÃ©, PhD, RRT</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>2645</phone_ext>
      <email>nathalie.gagne@criucpq.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Jean S BussiÃ¨res, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Etienne J Couture, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie GagnÃ©, PhD, RRT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Cheney FW, Posner KL, Lee LA, Caplan RA, Domino KB. Trends in anesthesia-related death and brain damage: A closed claims analysis. Anesthesiology. 2006 Dec;105(6):1081-6.</citation>
    <PMID>17122570</PMID>
  </reference>
  <reference>
    <citation>Cook TM, Woodall N, Frerk C; Fourth National Audit Project. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: anaesthesia. Br J Anaesth. 2011 May;106(5):617-31. doi: 10.1093/bja/aer058. Epub 2011 Mar 29.</citation>
    <PMID>21447488</PMID>
  </reference>
  <reference>
    <citation>Juvin P, Lavaut E, Dupont H, Lefevre P, Demetriou M, Dumoulin JL, Desmonts JM. Difficult tracheal intubation is more common in obese than in lean patients. Anesth Analg. 2003 Aug;97(2):595-600, table of contents.</citation>
    <PMID>12873960</PMID>
  </reference>
  <reference>
    <citation>Campbell IT, Beatty PC. Monitoring preoxygenation. Br J Anaesth. 1994 Jan;72(1):3-4. No abstract available. Erratum in: Br J Anaesth 1994 May;72(5):612.</citation>
    <PMID>8110546</PMID>
  </reference>
  <reference>
    <citation>Jense HG, Dubin SA, Silverstein PI, O'Leary-Escolas U. Effect of obesity on safe duration of apnea in anesthetized humans. Anesth Analg. 1991 Jan;72(1):89-93.</citation>
    <PMID>1984382</PMID>
  </reference>
  <reference>
    <citation>Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology. 1997 Oct;87(4):979-82.</citation>
    <PMID>9357902</PMID>
  </reference>
  <reference>
    <citation>Berthoud MC, Peacock JE, Reilly CS. Effectiveness of preoxygenation in morbidly obese patients. Br J Anaesth. 1991 Oct;67(4):464-6.</citation>
    <PMID>1931404</PMID>
  </reference>
  <reference>
    <citation>Murphy C, Wong DT. Airway management and oxygenation in obese patients. Can J Anaesth. 2013 Sep;60(9):929-45. doi: 10.1007/s12630-013-9991-x. Epub 2013 Jul 9.</citation>
    <PMID>23836064</PMID>
  </reference>
  <reference>
    <citation>Tanoubi I, Drolet P, Donati F. Optimizing preoxygenation in adults. Can J Anaesth. 2009 Jun;56(6):449-66. doi: 10.1007/s12630-009-9084-z. Epub 2009 Apr 28. Review.</citation>
    <PMID>19399574</PMID>
  </reference>
  <reference>
    <citation>Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006 May-Jun;13(4):203-10. Review.</citation>
    <PMID>16779465</PMID>
  </reference>
  <reference>
    <citation>Dixon BJ, Dixon JB, Carden JR, Burn AJ, Schachter LM, Playfair JM, Laurie CP, O'Brien PE. Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology. 2005 Jun;102(6):1110-5; discussion 5A.</citation>
    <PMID>15915022</PMID>
  </reference>
  <reference>
    <citation>Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg. 2003 Feb;13(1):4-9.</citation>
    <PMID>12630606</PMID>
  </reference>
  <reference>
    <citation>Burns SM, Egloff MB, Ryan B, Carpenter R, Burns JE. Effect of body position on spontaneous respiratory rate and tidal volume in patients with obesity, abdominal distension and ascites. Am J Crit Care. 1994 Mar;3(2):102-6.</citation>
    <PMID>8167771</PMID>
  </reference>
  <reference>
    <citation>Coussa M, Proietti S, Schnyder P, Frascarolo P, Suter M, Spahn DR, Magnusson L. Prevention of atelectasis formation during the induction of general anesthesia in morbidly obese patients. Anesth Analg. 2004 May;98(5):1491-5, table of contents.</citation>
    <PMID>15105237</PMID>
  </reference>
  <reference>
    <citation>Gander S, Frascarolo P, Suter M, Spahn DR, Magnusson L. Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. Anesth Analg. 2005 Feb;100(2):580-4.</citation>
    <PMID>15673897</PMID>
  </reference>
  <reference>
    <citation>Delay JM, Sebbane M, Jung B, Nocca D, Verzilli D, Pouzeratte Y, Kamel ME, Fabre JM, Eledjam JJ, Jaber S. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg. 2008 Nov;107(5):1707-13. doi: 10.1213/ane.0b013e318183909b.</citation>
    <PMID>18931236</PMID>
  </reference>
  <reference>
    <citation>Futier E, Constantin JM, Pelosi P, Chanques G, Massone A, Petit A, Kwiatkowski F, Bazin JE, Jaber S. Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study. Anesthesiology. 2011 Jun;114(6):1354-63. doi: 10.1097/ALN.0b013e31821811ba.</citation>
    <PMID>21478734</PMID>
  </reference>
  <reference>
    <citation>Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008 May;108(5):812-21.</citation>
    <PMID>18431116</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 9, 2014</lastchanged_date>
  <firstreceived_date>April 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Jean BussiÃ¨res</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Morbid Obesity</keyword>
  <keyword>Bariatric Surgery Candidate</keyword>
  <keyword>Pre-Oxygenation</keyword>
  <keyword>Functional Residual Capacity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
